Related Experiment Video
Updated: Apr 23, 2026

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
Cyclophilin D and myocardial ischemia-reperfusion injury: a fresh perspective
Muhammad Rizwan Alam1, Delphine Baetz1, Michel Ovize2
1INSERM U1060, CarMeN Laboratory, Claude Bernard Lyon 1 University, F-69373 Lyon, France.
Abstract:
Reperfusion is characterized by a deregulation of ion homeostasis and generation of reactive oxygen species that enhance the ischemia-related tissue damage culminating in cell death. The mitochondrial permeability transition pore (mPTP) has been established as an important mediator of ischemia-reperfusion (IR)-induced necrotic cell death. Although a handful of proteins have been proposed to contribute in mPTP induction, cyclophilin D (CypD) remains its only bona fide regulatory component. In this review we summarize existing knowledge on the involvement of CypD in mPTP formation in general and its relevance to cardiac IR injury in specific. Moreover, we provide insights of recent advancements on additional functions of CypD depending on its interaction partners and post-translational modifications. Finally we emphasize the therapeutic strategies targeting CypD in myocardial IR injury. This article is part of a Special Issue entitled "Mitochondria: From Basic Mitochondrial Biology to Cardiovascular Disease".
Insights
Cyclophilin D (CypD) is crucial for mitochondrial permeability transition pore (mPTP) opening during ischemia-reperfusion (IR) injury. Targeting CypD offers therapeutic potential for reducing cardiac IR damage.
Area of Science:
- Mitochondrial biology
- Cardiovascular disease
- Cell death mechanisms
Background:
- Ischemia-reperfusion (IR) injury involves ion deregulation and reactive oxygen species, leading to cell death.
- The mitochondrial permeability transition pore (mPTP) mediates IR-induced necrotic cell death.
- Cyclophilin D (CypD) is the sole confirmed regulator of mPTP induction.
Purpose of the Study:
- To review CypD's role in mPTP formation and cardiac IR injury.
- To discuss recent findings on CypD's additional functions.
- To highlight therapeutic strategies targeting CypD in myocardial IR injury.
Main Methods:
- Literature review of existing knowledge on CypD and mPTP.
- Analysis of recent research on CypD interactions and modifications.
- Synthesis of information on therapeutic interventions targeting CypD.
Main Results:
- CypD is a key mediator of mPTP opening in cardiac IR injury.
- CypD has diverse functions influenced by interaction partners and post-translational modifications.
- Targeting CypD presents a promising therapeutic avenue for myocardial IR injury.
Conclusions:
- CypD plays a central role in the pathophysiology of cardiac IR injury.
- Understanding CypD's multifaceted roles is essential for developing effective treatments.
- Therapeutic strategies focused on CypD hold significant promise for mitigating heart damage after IR events.
Related Concept Videos
Myocarditis I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy

